Skip to content
OpenCapital
Get started

AbbVie ABBV Free cash flow

Free cash flow at other companies

Eli Lilly logo
Eli LillyLLY
$3.01B+1,828%
Pfizer logo
PfizerPFE
$2.18B+23.0%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.47B-56.6%
Amgen logo
AmgenAMGN
$1.48B+50.7%
Cardinal Health logo
Cardinal HealthCAH
$1.68B-40.0%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
——

Other financials

Income statement

See full
Revenue$15.0B+12.4%
Gross profit$10.8B+15.4%
Operating income$4.0B+6.9%
Net income$695.0M-46.0%
EPS (diluted)$0.39-45.8%

Balance sheet

See full
Cash & equivalents$9.4B+81.5%
Total debt$62.4B+1.8%
Total equity-$6.7B-569%
Total assets$136.46B+0.2%

Cash flow

See full
Operating cash flow$3.8B+134%
CapEx$265.0M+12.8%

Valuation

See full
Market cap$429.58B+31.2%
P/E118.2×+40.2×
P/S6.8×+1.1×

Profitability

See full
Gross margin70.7%0.0pp
Operating margin24.4%—
Net margin5.8%-1.5pp
FCF margin31.8%+5.0pp

Returns & leverage

See full
Return on equity89%+32.7pp
Debt / equity46.6×+38.6×
Current ratio0.8×0.0×

Where this comes from

Calculated from AbbVie’s reported figures.

$3.8Bnet cash from operating−$265.0Mcapital expenditures=$3.56B

The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbbVie's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AbbVie's free cash flow?
AbbVie (ABBV) reported free cash flow of $3.56B in Q1 2026.
How has AbbVie's free cash flow changed year-over-year?
AbbVie's free cash flow increased by 154.6% year-over-year, from $1.4B to $3.56B.
What is the long-term trend for AbbVie's free cash flow?
Over 4 years (2021 to 2025), AbbVie's free cash flow has grown at a -5.1% compound annual growth rate (CAGR), from $21.99B to $17.82B.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.